首页 | 本学科首页   官方微博 | 高级检索  
     

肿瘤型假体重建膝关节周围原发性肿瘤切除后骨缺损
引用本文:Li WX,Ye ZM,Yang DS,Tao HM,Lin N,Yang ZM. 肿瘤型假体重建膝关节周围原发性肿瘤切除后骨缺损[J]. 中华外科杂志, 2007, 45(10): 665-668
作者姓名:Li WX  Ye ZM  Yang DS  Tao HM  Lin N  Yang ZM
作者单位:浙江大学医学院附属第二医院骨科,杭州,310009
摘    要:目的总结膝关节周围原发性骨肿瘤保肢手术中人工关节重建的疗效和并发症。方法回顾性分析我院1995年12月至2005年12月83例应用肿瘤型假体重建膝关节周围骨肿瘤切除后骨缺损的临床资料。其中骨肉瘤58例,多中心骨肉瘤2例,皮质旁骨肉瘤1例,恶性纤维组织细胞瘤4例,骨巨细胞瘤13例,平滑肌肉瘤1例,尤文肉瘤2例,软骨肉瘤2例。根据骨缺损重建部位分组:股骨下端组44例,胫骨上端组34例,全股骨置换组5例。结果所有患者均获得随访,随访时间12~130个月,平均41个月。局部复发6例,2例晚期感染,假体松动2例,无假体断裂;假体3、5年生存率分别为88.2%、82.1%。41例植骨患者形成皮质外骨桥。肢体肌肉骨骼肿瘤外科治疗重建术后功能评分:股骨下端组19.0—29.0分,平均25.0分;胫骨上端组17.0—28.0分,平均24.4分;全股骨置换组16.0—21.0分,平均19.0分。股骨下端组和胫骨上端组功能优于全股骨置换。结论肿瘤型人工关节重建膝关节周围骨肿瘤并发症发生率低,关节功能良好。

关 键 词:骨肿瘤 关节成形术  置换  膝 膝关节  人工
修稿时间:2007-01-04

Endoprosthetic reconstruction after wide resection of primary bone tumor around the knee
Li Wei-xu,Ye Zhao-ming,Yang Di-sheng,Tao Hui-min,Lin Nong,Yang Zheng-ming. Endoprosthetic reconstruction after wide resection of primary bone tumor around the knee[J]. Chinese Journal of Surgery, 2007, 45(10): 665-668
Authors:Li Wei-xu  Ye Zhao-ming  Yang Di-sheng  Tao Hui-min  Lin Nong  Yang Zheng-ming
Affiliation:Department of Orthopaedics, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, China
Abstract:OBJECTIVE: To evaluate the effect and complication of the endoprosthetic reconstruction after wide resection of primary bone tumor around the knee. METHODS: The retrospective analysis was performed on 83 patients undergoing the prosthetic reconstruction after the resection of the primary tumor around the knee between December 1995 and December 2005. All the diagnoses were pathologically confirmed (58 patients with osteosarcoma, 2 with osteosarcomatosis, 1 with parosteal osteosarcoma, 4 with malignant fibrous histiocytoma, 13 with giant cell tumor of bone, 1 with leiomyosarcoma, 2 with Ewing's sarcoma, 2 with chondrosacoma). The distal femur group was involved in 44 patients, proximal tibia group in 34 (including 33 deficit in proximal tibia, 1 deficit both in proximal tibia and distal femur), total femur replacement group in 5. After operation, the Musculoskeletal Tumor Society (MSTS) score was used to evaluate the recovery of their corresponding functions. RESULTS: The follow-up for 12 - 130 months (with a median of 41 months) revealed that the 3-year survival rate of the prosthesis was 88.2%, and the 5-year survival rate was 82.1%. As for the complications, local recurrence developed in 6 patients, periprosthesis infection in 2 patients, aseptic loosening in 2 patients. The mean MSTS core was 25.0 (19.0 - 29.0) in the distal femur group, 24.4 (17.0 - 28.0) in the proximal tibia group, and 19.0 (16.0 - 21.0) in the total femur replacement group. As to the statistical analysis, the function of the former two groups were greater than the latter one (F = 11.666, P < 0.001), however, there was no significant difference between the former 2 groups (F = 0.813, P = 0.370). CONCLUSIONS: Taken together, the tumor prosthesis gives a satisfactory functional outcome after the tumor around the knee is removed with a lower incidence of complication.
Keywords:Bone neoplasms   Arthoplasty, replacement, knee   Knee prosthesis
本文献已被 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号